Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.012
Neutral
RSI(14)
50.236
Neutral
STOCH(KDJ)(9,3,3)
56.133
Buy
ATR(14)
0.458
High Vlolatility
CCI(14)
63.688
Neutral
Williams %R
38.739
Buy
TRIX(12,20)
-0.228
Sell
StochRSI(14)
75.784
Neutral
Search
Eupraxia Pharmaceuticals Inc
EPRXAdd to Watchlist
6.400USD
-0.150-2.29%
Close 07-31 16:00（ET）Quotes delayed by 15 min
416.54MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.29%
5 Days
+10.15%
1 Month
-4.33%
6 Months
-18.78%
Year to Date
-15.23%
1 Year
+21.67%
Key Figures
6.550Open
6.740High
457.16KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.74%Turnover Ratio
6.550Prev. Close
6.150Low
2.34MTurnover
LossP/E Static
3.66P/B
0.00%Div Yield TTM
-50.97%ROA
12.86052wk High
0.72Volume Ratio
-25.50MNet Profit
61.81MShares
-0.9991EPS TTM
1.49Beta
-84.74%ROE
5.20052wk Low
9.01%Amplitude
--Gross Margin
416.54MMarket Cap
0.13Reward/Risk
3.60%Risk Rate
Eupraxia Pharmaceuticals Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Buy
Current Rating
16.444
Target Price
+156.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Eupraxia Pharmaceuticals Inc
EPRX
9
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
6.238
Buy
MA10
6.234
Buy
MA20
6.403
Sell
MA50
6.475
Sell
MA100
6.854
Sell
MA200
7.000
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Eupraxia Pharmaceuticals Inc Info
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The Company’s EP-104GI is in a Phase Ib/IIa trial, the RESOLVE trial, for the treatment of eosinophilic esophagitis (EoE). EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. The Company also completed a Phase IIb clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. In addition, the Company is developing a pipeline of later and earlier-stage long-acting formulations. Its potential pipeline indications include candidates for other inflammatory joint indications and oncology.
Ticker SymbolEPRX
CompanyEupraxia Pharmaceuticals Inc
CEOHelliwell (James A)
Websitehttps://eupraxiapharma.com/home/default.aspx
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52760.200
+382.200 (+0.73%)
28495.700
+334.800 (+1.19%)
7531.100
+56.000 (+0.75%)
14593.000
-156.000 (-1.06%)
63768.000
+916.000 (+1.46%)
6399.000
+33.600 (+0.53%)
78.090
-7.844 (-9.13%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4065.070
+23.640 (+0.58%)
FAQs
What is the current price of Eupraxia Pharmaceuticals Inc (EPRX)?
The current price of Eupraxia Pharmaceuticals Inc (EPRX) is 6.40.
What is the symbol of Eupraxia Pharmaceuticals Inc?
The ticker symbol of Eupraxia Pharmaceuticals Inc is EPRX.
What is the 52-week high of Eupraxia Pharmaceuticals Inc?
The 52-week high of Eupraxia Pharmaceuticals Inc is 12.86.
What is the 52-week low of Eupraxia Pharmaceuticals Inc?
The 52-week low of Eupraxia Pharmaceuticals Inc is 5.20.
What is the market capitalization of Eupraxia Pharmaceuticals Inc?
The market capitalization of Eupraxia Pharmaceuticals Inc is 416.54M.
Is Eupraxia Pharmaceuticals Inc (EPRX) currently rated as Buy, Hold, or Sell?
According to analysts, Eupraxia Pharmaceuticals Inc (EPRX) has an overall rating of Buy, with a price target of 16.44.
What is the Earnings Per Share (EPS TTM) of Eupraxia Pharmaceuticals Inc (EPRX)?
The Earnings Per Share (EPS TTM) of Eupraxia Pharmaceuticals Inc (EPRX) is -0.97.